Pfizer, the first US company to develop a vaccine against coronavirus, says it has developed a pill to be used in treatment against the omega coronary variant. These pills have been shown to be extremely effective in coronary heart disease patients and have resulted in an 89% reduction in inpatient mortality and hospital admissions.
The company said that the pills they have developed against the coronavirus were fed to 2,250 patients infected with different types of the corona, including omega-corona, with tremendous results and increased patient mortality and hospitalization rates. Decreased by 89%.
The tablets were also subjected to separate laboratory tests in which they were shown to be resistant to the new Corona variety, Omi Cron. These Pfizer pills are only for young patients who are in critical condition.
The company tried to develop a separate drug for low-risk people but failed. Pfizer says the drug failed to achieve its intended purpose. The drug helped the patients for four days but after that, they started showing symptoms of the corona. Although the trial of this drug failed, it resulted in a 70% reduction in hospital admissions for patients.
